Alzheimer’s disease is one of the most feared illnesses of aging. It slowly damages memory, thinking, and behavior, and over time it makes it difficult for people to carry out everyday tasks. For decades, scientists have focused mainly on one key feature of the disease: sticky clumps of a protein called amyloid that build up […]
Las Vegas is set to host a significant gathering of Alzheimer’s and Parkinson’s disease research leaders this week, as the Global Alzheimer’s Platform Foundation (GAP) convenes its annual conference from February 25th through February 27th at the Red Rock Casino Resort & Spa. The event will bring together nearly 250 representatives from over 100 clinical […]
by Chloe KoastTue, February 24, 2026 at 9:36 AM From February 25th through the 27th the Global Alzheimer’s Platform Foundation will meet up at the Red Rock Casino Resort & Spa. More than 250 representatives are coming together to not only network but also share their dedication to find the cure for Alzheimer’s. This includes announcing a new […]
The disease currently is diagnosed using expensive scans and lumbar punctures or spinal taps. February 18, 2026 By: Michael Barbella Managing Editor Alzheimer’s disease detection could be quite literally at our fingertips. A major international research project is underway at the U.K. Dementia Research Institute (DRI) to test whether a finger prick-style blood test could be […]
Diagnosing the disease can be expensive, invasive and complicated. Research in RI could help speed up the process Feb. 5, 2026, 5:04 a.m. ETEAST PROVIDENCE – Alzheimer’s, a neurodegenerative disease, is the primary cause of dementia in the United States. In Rhode Island, more than one in 10 adults over age 65 – about 22,000 […]
This Nature article highlights how blood-based biomarkers for Alzheimer’s disease stand to have the potential to transform diagnostics, and how new treatments and therapies are developed. There is mention of how Bio-Hermes-001, and Bio-Hermes-002, use head-to-head comparisons of blood-based biomarkers and digital tests to explore which combinations of blood-based biomarkers perform best across different populations and […]
Tori Rodriguez, MA, LPC, AHC Publish DateJanuary 27, 202 At the 18th Annual Clinical Trials on Alzheimer’s Disease (CTAD) conference, held December 1 to 4, 2025, in San Diego, California, researchers presented new data spanning observational studies, biomarker analyses, and clinical development programs in Alzheimer disease (AD). Key topics included emerging evidence on metabolic therapies such as […]
Alzheimer’s disease study brings new testing to Las Vegas Courtesy Axiom Brain Health’s Kaden Appleberry processes lab sample for study. By Katie Ann McCarver (contact) Monday, January 26, 2026 – 2 a.m. A Las Vegas stronghold in neurology is contributing to a new study spanning multiple states and countries related to the detection and diagnosis of Alzheimer’s disease. Clinical Neurology […]
by News 3 Staff,Updated Fri, January 23, 2026 at 1:20 PM LAS VEGAS (KSNV) — Clinical Neurology Specialists (CNS) in Las Vegas is participating in a groundbreaking international study sponsored by the Global Alzheimer’s Platform Foundation. The Bio-Hermes-002 study seeks volunteers with memory concerns to help identify blood or digital tests that could predict the presence of amyloid […]
Jan 20, 2026 | staff reporterSave for later NEW YORK — UK nonprofit research organization LifeArc said on Monday that it has partnered with the Global Alzheimer’s Platform Foundation (GAP) to evaluate a blood-based test for Alzheimer’s disease. The test is designed to detect three proteins — phosphorylated tau 217, glial fibrillary acidic protein, and neurofilament light […]
The test aims to pick up three proteins known to be associated with Alzheimer’s Jane KirbyMonday 19 January 2026 11:14 GMT Bookmark popover Removed from bookmarksClose popover A pioneering trial has begun to assess whether a simple finger-prick blood test could offer an early diagnosis for Alzheimer’s disease, even before symptoms manifest. Experts are optimistic […]
A major international research project is underway to test whether a finger prick-style blood test could be used to help diagnose Alzheimer’s disease. The trial is looking at three proteins in the blood that are associated with Alzheimer’s and comparing this with the current gold standard approach to diagnosing the disease that uses expensive brain […]
By Jacquelyn Voghel 01/18/2026 EAST PROVIDENCE – A national research institution’s Rhode Island location is calling for volunteers with Alzheimer’s disease to participate in a study attempting to identify predictive markers of the brain condition. K2 Medical Research – East Providence has begun enrolling participants in the Bio-Hermes 002 Study, an initiative of the Global Alzheimer’s Platform Foundation. The study seeks […]
K2 Now Enrolling in Innovative Study of Alzheimer’s Blood and Digital Biomarker Tests; Research Volunteers Receive No-Cost Brain Scan and Learn About Their Brain Health East Providence, RI- Jan 12, 2026 – – K2 Medical Research in Rhode Island has started enrolling volunteers with memory concerns in the Global Alzheimer’s Platform Foundation® (GAP)’s innovative Bio-Hermes-002 Study to […]
20 Dec ‘It’s the best time’: Family members may notice signs of Alzheimer’s at holiday gatherings Posted at 20:23h in Uncategorized by Belinda Russell 0 Comments ATLANTIS, Fla. — It’s the holiday season and while you celebrate with friends and family some experts say you may also notice some changes in elderly loved ones you haven’t seen for a while. Dr. Linda […]
Aging Emerging biomarkers and digital tools are unlocking earlier and more accurate diagnosis Teresa, 75, an Alzheimer’s patient and former businesswoman, poses for a photograph inside the Alzheimer Foundation, in Mexico City, Mexico, on April 19, 2012.REUTERS/Edgard Garrido by Lydia Wu, Jennifer Panlilio, Melissa Lee, Laura Nisenbaum, Aishu Sukumar December 10, 2025 Alzheimer’s disease and related dementias affect more than […]
About This Episode The quest to speed up clinical trials is personal for John Dwyer, CEO of the Global Alzheimer’s Platform (GAP). A long-time UsA2 advocate, he’s been motivated by the generations of family members lost to Alzheimer’s and Parkinson’s disease. Dwyer shares with BrainStorm host Meryl Comer the critical challenges of NIH funding cuts […]
November 19, 2025 Delivers Life-Changing Early Detection for 580,000 Floridians Living with Alzheimer’s WASHINGTON — Today, Congressman Vern Buchanan, Vice Chairman of the House Ways and Means Committee and Chair of the Health Subcommittee, announced the introduction of the Alzheimer’s Screening and Prevention (ASAP) Act alongside Congressman Paul Tonko (D-N.Y.). Senators Susan Collins (R-Maine) and Catherine Cortez Masto (D-Nev.) introduced companion legislation in the Senate. This bipartisan, bicameral […]
Last week, the Global Alzheimer’s Platform Foundation’s (GAP) Inclusive Research Initiative (IRI) team hosted its second annual virtual conference focused on improving Alzheimer’s and dementia research by increasing diversity among participants in neurodegenerative clinical trials. We are proud to have created a platform for meaningful dialogue and hope it has inspired new ideas, collaborations, and opportunities for those […]
IMPERIAL COUNTY, Calif. (KYMA) – The Sun Valley Research Center (SVRC) is taking a Mobile Research Unit on the road to hold free memory assessments. According to a press release, THOR (Taking Health on the Road) West is touring California and Arizona in order to help raise awareness of the importance of brain health.According to […]
How the U.S. can drive progress into the next era of Alzheimer’s disease careSponsored by Lilly Today, over 7 million Americans are living with Alzheimer’s disease — a number that is expected to more than double by 2060, according to the Alzheimer’s Association. The stakes for the U.S. health care system have never been higher. A […]
International non-profit Global Alzheimer’s Platform Foundation expands research network in California to improve access to research opportunities Washington D.C.- Global Alzheimer’s Platform Foundation® (GAP) announced in a recent press release the addition of Sun Valley Research Center (SVRC) a private clinical research organization based in Imperial, California, to its global network of over 100 best-in-class research sites. SVRC addresses the critical […]
Posted on October 2, 2025 • by Julia Ferrar Most biomarker tests, such as PET scans and spinal taps, are expensive or invasive and can pose risks for patients. That’s why a company in the Tampa Bay area is helping to research blood tests for biomarkers as a less expensive and more accessible alternative. Axiom […]
FOX 13’s Allie Corey and her guest discuss Alzheimer’s and the latest research in the disease. Watch the interview with Dr. Steen of Axiom Brain Health here: https://www.fox13news.com/video/1715786